DEPLOYDatabase

Deployment

hinotori at Shizuoka Cancer Center

Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.

hinotori by Medicaroid · Catalog entry · 1 source · not yet field-verified · Surgical robots

Track hinotori at Shizuoka Cancer Center

Shizuoka Cancer Center launched the world's first clinical study for autonomous surgery with hinotori in December 2023. Also performs robotic gastrectomy for gastric cancer.

Safety record

No incidents on record for hinotori at Shizuoka Cancer Center.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-09
Model
hinotori
Company
Medicaroid
Location
Shizuoka Cancer Center
Status
operational
First seen
2023-12-01
ID
546b7d05-b8ee-4141-884d-9f307aaf1e0c

Timeline

  1. Dec 2023
    First recorded
    hinotori first documented operating at Shizuoka Cancer Center.
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Operates worldwide

hinotori is deployed globally rather than at a single verified site, so there is no map pin.

Free to use on your site, with a link back to DEPLOY.

hinotori operates in Shizuoka Cancer Center. Explore the full verified map:

Sources (1)

  1. https://www.scchr.jp/en/topics/topics_20231221.html
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for hinotori at Shizuoka Cancer Center.

Common questions

What is the hinotori deployment at Shizuoka Cancer Center?
hinotori, built by Medicaroid, is recorded as a deployment at Shizuoka Cancer Center on the DEPLOY registry. Medicaroid operates the deployment directly.
Who operates hinotori at Shizuoka Cancer Center?
Medicaroid, the manufacturer of hinotori, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the hinotori deployment at Shizuoka Cancer Center go live?
The deployment is recorded as starting December 1, 2023 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the hinotori deployment at Shizuoka Cancer Center?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces